Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Treasury yields are pushing higher amid another rally in energy prices; market mea sures of inflation expectations have reached their highest level since early-2023. Elsewhere, Magnificent Seven ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

The tech world is buzzing with exciting developments and innovations every day, let's find out what's new has been introduced ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Google has released a whole new range of AI-powered research and interactions that simply can't be matched by DeepSeek or OpenAI.

Looking ahead, Google’s new CFO Ruth Porat forecast capital expenditures (CAPEX) for fiscal year 2025, which is expected to ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

From packable sleeping pads to ultracomfortable air beds, we tested and found the best camping mattresses and sleeping pads ...

(Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals (NASDAQ: VRTX )' drug to treat acute ...